Predictive Oncology shares owned by Vanguard Group
Quarter-by-quarter ownership of Predictive Oncology (POAI) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Predictive Oncology
Tip: Access up to 7 years of quarterly data
All positions including Predictive Oncology held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Predictive Oncology by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $74k | 71k | 1.04 |
| 2024-03-31 | $366k | 144k | 2.55 |
| 2023-12-31 | $463k | 141k | 3.29 |
| 2023-09-30 | $450k | 141k | 3.20 |
| 2023-06-30 | $683k | 141k | 4.86 |